Literature DB >> 31313070

The value of nutritional supplements in treating Age-Related Macular Degeneration: a review of the literature.

Sabrina Mukhtar1, Balamurali K Ambati2.   

Abstract

PURPOSE: To describe and evaluate the value of nutritional supplements in the management of age-related macular degeneration (AMD) through a review of the current literature.
METHODS: An extensive literature search was performed, and key research articles exploring AREDS and AREDS-2 formulations, genetics, omega fatty acids, calcium and folic acid in high-risk women were reviewed. PubMed and Web of Science databases were used for generating articles to review.
RESULTS: The AREDS and AREDS-2 trials, while difficult to validate, show support for antioxidant supplementation in reducing AMD progression in Caucasian populations. While genetic guided personalized medicine has been studied mainly with complement factor H and age-related maculopathy susceptibility 2 risk alleles, the data have not been reproducible. Women at a higher risk of cardiovascular disease may benefit from antioxidant therapies in preventing AMD. Omega 3 fatty acid supplementation has been widely supported through observational studies; however, randomized controlled trials have not shown benefit in disease progression. Calcium exposure has been linked to increased mechanisms in cell death and may be detrimental to older individuals with AMD.
CONCLUSION: The data regarding nutritional supplements in preventing AMD progression are inconclusive, and therefore recommendations should be based on risk factors and demographic data.

Entities:  

Keywords:  Macular degeneration; Nutrition; Public health; Retina

Mesh:

Substances:

Year:  2019        PMID: 31313070     DOI: 10.1007/s10792-019-01140-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  73 in total

1.  Evaluation of plasma homocysteine and risk of age-related macular degeneration.

Authors:  Johanna M Seddon; Gary Gensler; Michael L Klein; Roy C Milton
Journal:  Am J Ophthalmol       Date:  2006-01       Impact factor: 5.258

2.  Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial.

Authors:  Giuseppe Querques; Bénédicte M J Merle; Nicole M Pumariega; Pascale Benlian; Cécile Delcourt; Alain Zourdani; Heather B Leisy; Michele D Lee; R Theodore Smith; Eric H Souied
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

Review 3.  Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors.

Authors:  Sanja Stankovic; Nada Majkic-Singh
Journal:  Crit Rev Clin Lab Sci       Date:  2010 Mar-Apr       Impact factor: 6.250

4.  Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.

Authors:  F Nappo; N De Rosa; R Marfella; D De Lucia; D Ingrosso; A F Perna; B Farzati; D Giugliano
Journal:  JAMA       Date:  1999-06-09       Impact factor: 56.272

5.  Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration.

Authors:  Gunhal Kamburoglu; Koray Gumus; Sibel Kadayifcilar; Bora Eldem
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-15       Impact factor: 3.117

Review 6.  NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake.

Authors: 
Journal:  JAMA       Date:  1994-12-28       Impact factor: 56.272

7.  Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.

Authors:  Eric H Souied; Cécile Delcourt; Giuseppe Querques; Ana Bassols; Bénédicte Merle; Alain Zourdani; Theodore Smith; Pascale Benlian
Journal:  Ophthalmology       Date:  2013-02-08       Impact factor: 12.079

8.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

Authors:  Christine M Albert; Nancy R Cook; J Michael Gaziano; Elaine Zaharris; Jean MacFadyen; Eleanor Danielson; Julie E Buring; JoAnn E Manson
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

9.  Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.

Authors:  Carl C Awh; Steven Hawken; Brent W Zanke
Journal:  Ophthalmology       Date:  2014-09-04       Impact factor: 12.079

10.  Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1993-01
View more
  8 in total

1.  Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice.

Authors:  Yan Gong; Yohei Tomita; Matthew L Edin; Anli Ren; Minji Ko; Jay Yang; Edward Bull; Darryl C Zeldin; Ann Hellström; Zhongjie Fu; Lois E H Smith
Journal:  Metabolism       Date:  2022-07-19       Impact factor: 13.934

Review 2.  Implications of NAD+ Metabolism in the Aging Retina and Retinal Degeneration.

Authors:  Ravirajsinh N Jadeja; Menaka C Thounaojam; Manuela Bartoli; Pamela M Martin
Journal:  Oxid Med Cell Longev       Date:  2020-05-09       Impact factor: 6.543

Review 3.  Antioxidants for the Treatment of Retinal Disease: Summary of Recent Evidence.

Authors:  Patrick Wang; Eric K Chin; David Almeida
Journal:  Clin Ophthalmol       Date:  2021-04-19

Review 4.  The Vertical and Horizontal Pathways in the Monkey Retina Are Modulated by Typical and Atypical Cannabinoid Receptors.

Authors:  Joseph Bouskila; Maxime Bleau; Catarina Micaelo-Fernandes; Jean-François Bouchard; Maurice Ptito
Journal:  Cells       Date:  2021-11-13       Impact factor: 6.600

Review 5.  Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review.

Authors:  Justin C Muste; Matthew W Russell; Rishi P Singh
Journal:  Clin Ophthalmol       Date:  2021-09-02

Review 6.  Long-Chain Polyunsaturated Fatty Acids and Their Metabolites Regulate Inflammation in Age-Related Macular Degeneration.

Authors:  Jiangbo Ren; Anli Ren; Xizhi Deng; Zhengrong Huang; Ziyu Jiang; Zhi Li; Yan Gong
Journal:  J Inflamm Res       Date:  2022-02-09

Review 7.  Curcumin in Retinal Diseases: A Comprehensive Review from Bench to Bedside.

Authors:  Davide Allegrini; Raffaele Raimondi; Alfredo Borgia; Tania Sorrentino; Giovanni Montesano; Panos Tsoutsanis; Giuseppe Cancian; Yash Verma; Francesco Paolo De Rosa; Mario R Romano
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 8.  Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options.

Authors:  Ana Rita Fernandes; Aleksandra Zielińska; Elena Sanchez-Lopez; Tiago Dos Santos; Maria Luisa Garcia; Amelia M Silva; Jacek Karczewski; Eliana B Souto
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.